Document Detail


Enhancement of transdermal delivery of heparin by various physical and chemical enhancement techniques.
MedLine Citation:
PMID:  20402624     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Conventional anticoagulants such as unfractionated heparin and warfarin have numerous limitations compared with low-molecular-weight heparin (LMWH). However, the need for repetitive parenteral administration is still a major disadvantage of LMWH, and the absorption of macromolecules such as LMWH across the gastrointestinal tract is very poor. Due to these problems with oral delivery of LMWH, transdermal delivery can be considered as an alternate route of administration. However, overcoming the skin barrier is necessary for the transport of larger molecules across the stratum corneum. This review focuses on the transdermal delivery of LMWH, providing a brief overview of heparin delivery via invasive and oral routes and discusses the advantages of using LMWH rather than heparin for transdermal delivery, and the primary reasons for poor permeability of LMWH. Various strategies employed for transdermal delivery of heparin are summarized, and chemical and physical enhancement techniques or suitable formulations that can be used to improve transcutaneous penetration and various chemical enhancers that act on the skin by different modes of action are discussed. We also consider physical approaches such as iontophoresis, electroporation, and ultrasound, as well as combination strategies to deliver heparin. The developments in physical and chemical enhancement strategies over the past decade are summarized. In addition, recent novel approaches such as microneedles employed for the transdermal delivery of LMWH are also discussed.
Authors:
S S Lanke; J G Strom; A K Banga
Related Documents :
20650124 - Application of in vitro systems to the prediction of in vivo biokinetics.
3385214 - Bioavailability of topically administered steroids: a "mass balance" technique.
7532944 - B-cell epitopes of allergens determined by recombinant techniques; use for diagnosis an...
22658574 - Estimating gfr among participants in the chronic renal insufficiency cohort (cric) study.
12402094 - Measuring positive, negative, and null impacts of forest disturbances: a case study usi...
17475394 - Applying choice experiments to valuing the different types of environmental issues in j...
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Critical reviews in therapeutic drug carrier systems     Volume:  26     ISSN:  0743-4863     ISO Abbreviation:  Crit Rev Ther Drug Carrier Syst     Publication Date:  2009  
Date Detail:
Created Date:  2010-04-20     Completed Date:  2010-07-08     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8511159     Medline TA:  Crit Rev Ther Drug Carrier Syst     Country:  United States    
Other Details:
Languages:  eng     Pagination:  581-606     Citation Subset:  IM    
Affiliation:
Department of Pharmaceutical Sciences, College of Pharmacy and Health Sciences, Mercer University, Atlanta, GA 30341, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Administration, Cutaneous
Animals
Anticoagulants / administration & dosage*,  pharmacokinetics
Electroporation / methods
Excipients / chemistry
Heparin, Low-Molecular-Weight / administration & dosage*,  pharmacokinetics
Humans
Iontophoresis
Needles
Permeability
Skin / metabolism
Skin Absorption*
Chemical
Reg. No./Substance:
0/Anticoagulants; 0/Excipients; 0/Heparin, Low-Molecular-Weight

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Lipid-based nanoparticles as pharmaceutical drug carriers: from concepts to clinic.
Next Document:  Specific complications of the mobile-bearing total knee prosthesis.